Table 1.
Demographic, Disease, and Treatment Characteristics of Subjects With and Without Latent Toxoplasma gondii Infection
| Characteristic | LTI– (n = 233) | LTI+ (n = 30) | P Value |
|---|---|---|---|
| Age, y, mean (SD) | 41.8 (9.1) | 44.6 (10.4) | .12 |
| Education, y, mean (SD) | 12.6 (2.4) | 12.4 (2.9) | .82 |
| Male sex, No. (%) | 211 (91) | 26 (87) | .51 |
| Ethnicity, No. (%) | .81 | ||
| Black | 36 (15) | 5 (17) | |
| Hispanic | 49 (21) | 7 (23) | |
| White | 138 (59) | 16 (53) | |
| Other | 10 (4) | 2 (7) | |
| HIV RNA in plasma, log10 copies/mLa, mean (SD) | 3.0 (1.4) | 2.7 (1.3) | .34 |
| Undetectablea, No. (%) | 94 (44) | 17 (57) | .18 |
| ART useb, No. (%) | 161 (69) | 22 (76) | .47 |
| On ART and RNA undetectablec, No. (%) | 92 (43) | 17 (59) | .11 |
| CD4+ count, cells/µLd, median (IQR) | 395 (214–583) | 330 (238–535) | .98 |
| CD4+ nadir, cells/µLe, median (IQR) | 211 (63–280) | 195 (176–281) | .91 |
| GDS ≥ 0.5, No. (%) | 79 (34) | 17 (57) | .017 |
Abbreviations: –, negative; +, positive; ART, antiretroviral therapy; GDS, global deficit score; HIV, human immunodeficiency virus; IQR, interquartile range; LTI, latent Toxoplasma infection; SD, standard deviation.
a n = 216 for LTI–.
b n = 232 for LTI– and n = 29 for LTI+.
c n = 215 for LTI– and n = 29 for LTI+.
d n = 221 for LTI– and n = 29 for LTI+.
e n = 105 for LTI– and n = 12 for LTI+.